Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease

Objective: Several models have been proposed for the evolution of Alzheimer’s disease (AD) biomarkers. The aim of this study was to identify changepoints in a range of biomarkers during the preclinical phase of AD. Methods: We examined nine measures based on cerebrospinal fluid (CSF), magnetic reson...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Aging Neurosci
Autors principals: Younes, Laurent, Albert, Marilyn, Moghekar, Abhay, Soldan, Anja, Pettigrew, Corinne, Miller, Michael I.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6454004/
https://ncbi.nlm.nih.gov/pubmed/31001108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00074
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars